Literature DB >> 28464260

Cellular Migration Ability Is Modulated by Extracellular Purines in Ovarian Carcinoma SKOV-3 Cells.

A S Martínez-Ramírez1, M Díaz-Muñoz1, A M Battastini2, A Campos-Contreras1, A Olvera1, L Bergamin3, T Glaser3, C E Jacintho Moritz2, H Ulrich3, F G Vázquez-Cuevas1.   

Abstract

Extracellular nucleotides and nucleosides have emerged as important elements regulating tissue homeostasis. Acting through specific receptors, have the ability to control gene expression patterns to direct cellular fate. We observed that SKOV-3 cells express the ectonucleotidases: ectonucleotide pyrophosphatase 1 (ENPP1), ecto-5'-nucleotidase (NT5E), and liver alkaline phosphatase (ALPL). Strikingly, in pulse and chase experiments supplemented with ATP, SKOV-3 cells exhibited low catabolic efficiency in the conversion of ADP into AMP, but they were efficient in converting AMP into adenosine. Since these cells release ATP, we proposed that the conversion of ADP into AMP is a regulatory node associated with the migratory ability and the mesenchymal characteristics shown by SKOV-3 cells under basal conditions. The landscape of gene expression profiles of SKOV-3 cell cultures treated with apyrase or adenosine demonstrated similarities (e.g., decrease FGF16 transcript) and differences (e.g., the negative regulation of Wnt 2, and 10B by adenosine). Thus, in SKOV-3 we analyzed the migratory ability and the expression of epithelium to mesenchymal transition (EMT) markers in response to apyrase. Apyrase-treatment favored the epithelial-like phenotype, as revealed by the re-location of E-cadherin to the cell to cell junctions. Pharmacological approaches strongly suggested that the effect of Apyrase involved the accumulation of extracellular adenosine; this notion was strengthened when the incubation of the SKOV-3 cell with α,β-methylene ADP (CD73 inhibitor) or adenosine deaminase was sufficient to abolish the effect of apyrase on cell migration. Overall, adenosine signaling is a fine tune mechanism in the control of cell phenotype in cancer. J. Cell. Biochem. 118: 4468-4478, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  ADENINE NUCLEOTIDES; ADENOSINE; APYRASE; CELLULAR MIGRATION; OVARIAN CARCINOMA

Mesh:

Substances:

Year:  2017        PMID: 28464260     DOI: 10.1002/jcb.26104

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Adenosine Receptor A2B Negatively Regulates Cell Migration in Ovarian Carcinoma Cells.

Authors:  Anaí Del Rocío Campos-Contreras; Adriana González-Gallardo; Mauricio Díaz-Muñoz; Francisco G Vázquez-Cuevas
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

Review 2.  Autocrine and paracrine purinergic signaling in the most lethal types of cancer.

Authors:  M Reyna-Jeldes; M Díaz-Muñoz; J A Madariaga; C Coddou; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2021-05-12       Impact factor: 3.765

Review 3.  Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity.

Authors:  Juliana Hofstätter Azambuja; Nils Ludwig; Elizandra Braganhol; Theresa L Whiteside
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

Review 4.  Purinergic Signaling in the Hallmarks of Cancer.

Authors:  Anaí Del Rocío Campos-Contreras; Mauricio Díaz-Muñoz; Francisco G Vázquez-Cuevas
Journal:  Cells       Date:  2020-07-03       Impact factor: 6.600

Review 5.  Targeting purine metabolism in ovarian cancer.

Authors:  Jingchun Liu; Shasha Hong; Jiang Yang; Xiaoyi Zhang; Ying Wang; Haoyu Wang; Jiaxin Peng; Li Hong
Journal:  J Ovarian Res       Date:  2022-08-13       Impact factor: 5.506

6.  CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer.

Authors:  Zhijun Xu; Chuncai Gu; Xingxing Yao; Weihong Guo; Huanan Wang; Tian Lin; Fengping Li; Da Chen; Jianhua Wu; Gengtai Ye; Liying Zhao; Yanfeng Hu; Jiang Yu; Jiaolong Shi; Guoxin Li; Hao Liu
Journal:  Cell Death Dis       Date:  2020-03-23       Impact factor: 8.469

7.  Increased Purinergic Responses Dependent on P2Y2 Receptors in Hepatocytes from CCl4-Treated Fibrotic Mice.

Authors:  Erandi Velázquez-Miranda; Christian Molina-Aguilar; Adriana González-Gallardo; Olivia Vázquez-Martínez; Mauricio Díaz-Muñoz; Francisco G Vázquez-Cuevas
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

8.  Generation of a Retargeted Oncolytic Herpes Virus Encoding Adenosine Deaminase for Tumor Adenosine Clearance.

Authors:  Chiara Gentile; Arianna Finizio; Guendalina Froechlich; Anna Morena D'Alise; Gabriella Cotugno; Sara Amiranda; Alfredo Nicosia; Elisa Scarselli; Nicola Zambrano; Emanuele Sasso
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.